8th Annual Pharma IPR Conference


Taj Lands End
Bandstand Fort, BJ Road, Mount Mary, Bandra West 
Mumbai, Maharashtra 400050

Date & Time

Start Date: 03/06/2019
End Date: 03/08/2019


Martin Pavane, vice chair of Cozen O'Connor's Intellectual Property department, and Blake Coblentz, a member of the firm's Intellectual Property department, will be speaking at this event in Mumbai, Maharashtra. Martin and Blake will be presenting "Global Perspective: Patent Linkage." The Indian Pharma industry has generated astounding growth in the past decades fuelled by increasing burden of disease. In order for the Indian pharmaceutical industry to maximize its true potential, ideation, innovation, and integration are pre-requisites to reaching this stupendous growth. The numerous innovations leading to discovery of new life-saving drugs are through intellectual property rights (IPRs). IPR is a requirement for pharma companies for identification, planning, commercialization and protection of invention. The intellectual property market has manifested growth at an unprecedented pace. Risks abound and rights holders need strategic knowledge to maximize their success in the jurisdiction. The Patent Act, 1970 has played a significant role in taking India to the global patent arena.


Share on LinkedIn


W. Blake Coblentz

Co-Chair, Hatch-Waxman & Biologics
Vice Chair, Intellectual Property


(202) 912-4837

Related Practices